semaglutide or tirzepatide weight loss vs Weight loss: Semaglutide or tirzepatide,

CT showed tissular expansive tumor with obscure boundary, leading to extensive bone destruction, local spiculated periosteal reaction and fragmentary cortical bone

Analysis of the SELECT trialassessing the cardiovascular impact of the diabetes and anti-obesity medication semaglutide (Wegovy, Novo Nordisk)has found that the use of the drug significantly reduced the risk of major adverse cardiovascular events (MACE) regardless of the amount of weight individuals lost

Diversit della Popolazione: La popolazione dello studio STEP 1 era pi giovane, pi sana e includeva una percentuale maggiore di donne rispetto a SELECT

But there's a story developing that most people aren't talking about yet: these drugs aren't just helping people lose weight